Gratus Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Gratus Capital's GILD Position: Q2 2024 in Review
Gratus Capital increased its Gilead Sciences (GILD) stake by 9.1% in Q2 2024, buying an estimated $19.6K and bringing the position to 3,539 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #327.
Gratus Capital first reported a position in GILD in Q4 2014 and has held it in 14 quarters since. The position peaked at $7.57M in Q4 2015. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- Gratus Capital held 3,539 shares of Gilead Sciences worth $243K as of Q2 2024.
- Gratus Capital bought 294 Gilead Sciences shares in Q2 2024, an estimated $19.6K.
- Gilead Sciences made up 0.01% of Gratus Capital's portfolio in Q2 2024, its #327 holding.
- Gratus Capital first reported a position in Gilead Sciences in Q4 2014 and has held it in 14 quarters since.
- Gratus Capital's Gilead Sciences position peaked at $7.57M in Q4 2015.
- 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on Gratus Capital's 13F filing for Q2 2024, filed 25 Jul 2024.